These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2963662)
1. Evidence for altered opioid activity in patients with cancer. Lissoni P; Barni S; Paolorossi F; Crispino S; Rovelli F; Ferri L; Delitala G; Tancini G Br J Cancer; 1987 Dec; 56(6):834-7. PubMed ID: 2963662 [TBL] [Abstract][Full Text] [Related]
2. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee. Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210 [TBL] [Abstract][Full Text] [Related]
3. Alteration of opioid peptide circadian rhythm in cancer patients. Barni S; Lissoni P; Rovelli F; Crispino S; Paolorossi F; Esposti D; Esposti G; Fraschini F; Tancini G Tumori; 1988 Jun; 74(3):357-60. PubMed ID: 2969639 [TBL] [Abstract][Full Text] [Related]
4. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion. Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297 [TBL] [Abstract][Full Text] [Related]
5. Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases. Demura R; Suda T; Wakabayashi I; Yoshimura M; Jibiki K; Odagiri E; Demura H; Shizume K J Clin Endocrinol Metab; 1981 Feb; 52(2):263-6. PubMed ID: 7462391 [TBL] [Abstract][Full Text] [Related]
6. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease. Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423 [TBL] [Abstract][Full Text] [Related]
7. Agonists of endogenous opioid peptides suppress LH, and stimulate cortisol and growth hormone during the follicular phase in heifers. Armstrong JD; Johnson BH J Endocrinol; 1989 Apr; 121(1):11-7. PubMed ID: 2541216 [TBL] [Abstract][Full Text] [Related]
8. Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons. Ganzetti I; Petraglia F; Capuano I; Rosi F; Wehrenberg WB; Müller EE; Cocchi D J Endocrinol Invest; 1987 Jun; 10(3):241-6. PubMed ID: 2957419 [TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine receptor stimulation on the inhibition of LH pulsatility by a met-enkephaline (FK 33-824). del Pozo E; Martin-Perez J Acta Neurochir (Wien); 1985; 75(1-4):88-90. PubMed ID: 2986425 [TBL] [Abstract][Full Text] [Related]
10. Effect of adrenergic antagonism on the growth hormone, prolactin and cortisol response to a synthetic opioid agonist in man. Bouloux PM; Grossman A; Allolio B; Delitala G; Besser GM Horm Res; 1986; 23(2):83-90. PubMed ID: 2935474 [TBL] [Abstract][Full Text] [Related]
11. Effects of a [Met]-enkephalin analogue ( [D-Ala2,N-Me-Phe4,Met-(O)5-ol]-enkephalin) on canine pituitary function. Meij BP; Rijnberk A; Mol JA J Endocrinol; 1990 Nov; 127(2):265-71. PubMed ID: 2174454 [TBL] [Abstract][Full Text] [Related]
12. Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases. Demura R; Suda T; Wakabayashi I; Ono M; Jibiki K; Odagiri E; Demura H; Shizume K Tohoku J Exp Med; 1982 Jul; 137(3):283-7. PubMed ID: 6810504 [TBL] [Abstract][Full Text] [Related]
13. Plasma growth hormone and prolactin response to FK 33-824, a synthetic opioid agonist, in broiler chickens. Edens FW; Parkhurst CR Poult Sci; 1994 Nov; 73(11):1746-54. PubMed ID: 7862614 [TBL] [Abstract][Full Text] [Related]
14. The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol and thyroid stimulating hormone in healthy elderly men. Giusti M; Delitala G; Marini G; Uggias B; Sessarego P; Besser GM; Grossman A; Giordano G Acta Endocrinol (Copenh); 1992 Sep; 127(3):205-9. PubMed ID: 1414144 [TBL] [Abstract][Full Text] [Related]
15. A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerations. Esposti D; Lissoni P; Tancini G; Barni S; Crispino S; Paolorossi F; Rovelli F; Ferri L; Cattaneo G; Esposti G Cancer; 1988 Aug; 62(3):494-9. PubMed ID: 2968835 [TBL] [Abstract][Full Text] [Related]
16. Involvement of alpha-adrenergic mechanisms in growth hormone release induced by opioid peptides in conscious rats. Katakami H; Kato Y; Matsushita N; Hiroto S; Shimatsu A; Imura H Neuroendocrinology; 1981 Sep; 33(3):129-35. PubMed ID: 6117022 [TBL] [Abstract][Full Text] [Related]
17. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats. Leadem CA; Kalra SP Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342 [TBL] [Abstract][Full Text] [Related]
18. Endocrine effect of a methionine-enkephalin derivative (FK 33-824) in man. del Pozo E; von Graffenried B; Brownell J; Derrer F; Marbach P Horm Res; 1980; 13(2):90-7. PubMed ID: 6262206 [TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenous opioid peptides in the neuroendocrine response of ewe lambs to the introduction of a ram. Stansfield SC; Knight PG; Al-Mauly NZ; Bryant MJ J Endocrinol; 1987 Nov; 115(2):333-9. PubMed ID: 2963889 [TBL] [Abstract][Full Text] [Related]
20. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey. Gilbeau PM; Almirez RG; Holaday JW; Smith CG J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]